A one year postdoctoral position in the Division of Human Gene Therapy is available to study the use of conditionally replicating adenoviral vectors for ovarian cancer therapy. Novel vector enhancements will be explored including incorporation of imaging and therapeutic agents. Other areas of study may include: viral vector systems and mechanisms of virus-based gene transfer; replicative systems; molecular targeting; molecular ablation; molecular chemotherapy; anti-angiogenesis; combination therapies; and imaging analysis.

 

Please send a brief cover letter, curriculum vitae, and the names of three references to:

 

David T. Curiel, M.D., Ph.D., Director

 

Division of Human Gene Therapy

 

Gene Therapy Center

 

The University of Alabama at Birmingham

 

901 19th Street, South, BMR2 Room 508

 

Birmingham, Alabama 35294

 

Email: curiel@uab.edu